Sjogren's syndrome (SS) is a slowly progressing autoimmune disease, affecting
predominantly middle-aged women, with a female to male ratio reaching 9: 1. It is …

Sjögren's syndrome (SjS) is a systemic autoimmune disease, characterized by the presence
of periductal lymphocytic infiltrations in salivary and lachrymal glands resulting in oral and …

• Mild chronic renal compromise34 continued association with antibodies against
neuropeptides. 42 Increased rates of neuroticism, psychoticism, obsessiveness …

Objective: To investigate the effect of the tumour necrosis factor (TNF) blocking agent
infliximab in patients with treatment-resistant inflammatory myopathies. Methods: A total of …

Both type I and II interferons (IFNs) have been implicated in the pathogenesis of Sjogren's
syndrome (SS). We aimed to explore the contribution of type I and II IFN signatures in the …

The heightened risk of non-Hodgkin lymphoma (NHL) development in primary Sjogren
syndrome (SS) is well established. Several adverse clinical and laboratory predictors have …

Objective Increased expression of type I interferon (IFN) and a broad signature of type I IFN–
induced gene transcripts are observed in patients with systemic lupus erythematosus (SLE) …

Heightened rates of both cardiovascular (CV) events and subclinical atherosclerosis,
documented by imaging and vascular function techniques are well established in systemic …

Sjogren's syndrome (SS), a chronic autoimmune systemic disease affecting middle aged
women, is characterized by lymphocytic infiltration of the salivary and lachrymal glands …

Objective. Recent clinical trials suggest that etan-ercept is ineffective in controlling Sjögren's
syndrome (SS). To address the hypothesis that tumor necrosis factor blockade can result in …